National Blood Authority website

Annual Report Home

Table of Contents

Image: Annual Report Cover

National Blood Authority Australia – Annual Report 2008–2009

Part Six. Appendices

Appendix 1. The National Blood Agreement: objectives of governments

  1. The primary policy objectives for the Australian blood sector are:
    1. to provide an adequate, safe, secure and affordable supply of blood products, blood-related products and blood-related services in Australia; and
    2. to promote safe, high quality management and use of blood products, blood-related products and blood-related services in Australia.
  2. In pursuing the primary policy objectives, the Parties will have regard to the following secondary policy aims:
    1. to meet international obligations and standards;
    2. to maintain reliance on voluntary, non-remunerated donations of whole blood and plasma;
    3. to promote national self-sufficiency;
    4. to provide products to patients, free of charge and based on clinical need and appropriate clinical practice;
    5. to promote optimal safety and quality in the supply, management and use of products, including through uniform national standards;
    6. to make best use of available resources, and to give financial and performance accountability for the use of resources by all entities involved in the Australian blood sectors;
    7. to undertake national information gathering, monitoring of new developments, reporting and research in relation to the Australian blood sectors;
    8. to maintain flexibility and capacity to respond in a timely manner to changing circumstances and needs;
    9. to ensure public support and confidence in the Australian blood sector; and
    10. to work towards optimal access to blood products and blood-related products across the nation, ensuring that patients continue to access the blood products and blood-related products their clinicians determine will best meet their needs so far as practicable in accordance with national best practice based on clinical guidelines. This clause does not preclude States and Territories from altering the range of blood products and blood-related products that are prescribed and received in their jurisdiction.

Top of Page

Previous Page | Next Page